Clinical trials
Spasms, Infantile trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
47 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 3 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 4 |
| 2013 | 2 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 5 |
| 2018 | 3 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 4 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 19 |
| Terminated | 8 |
| Unknown status | 7 |
| Recruiting | 5 |
| Withdrawn | 4 |
| Active, not recruiting | 2 |
| Suspended | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lady Hardinge Medical College | 5 |
| All India Institute of Medical Sciences | 3 |
| Jazz Pharmaceuticals | 3 |
| University of Colorado, Denver | 3 |
| Assistance Publique - Hôpitaux de Paris | 2 |
| Lundbeck LLC | 2 |
| Marinus Pharmaceuticals | 2 |
| Amzell | 1 |
| Ann & Robert H Lurie Children's Hospital of Chicago | 1 |
| Bio-Pharm Solutions Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Spasms, Infantile | 47 |
| Epilepsy | 9 |
| Seizures | 9 |
| Lennox Gastaut Syndrome | 5 |
| Epilepsies, Myoclonic | 4 |
| Central Nervous System Diseases | 2 |
| Epilepsies, Partial | 2 |
| Malformations of Cortical Development | 2 |
| Nervous System Diseases | 2 |
| Recurrence | 2 |
Trials
Showing 26 to 47 of 47. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.